101 related articles for article (PubMed ID: 32020064)
21. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
Park CY; Kim DK; Sheen YY
Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation.
Lu SL; Reh D; Li AG; Woods J; Corless CL; Kulesz-Martin M; Wang XJ
Cancer Res; 2004 Jul; 64(13):4405-10. PubMed ID: 15231647
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas.
Benefield J; Petruzzelli GJ; Fowler S; Taitz A; Kalkanis J; Young MR
Invasion Metastasis; 1996; 16(6):291-301. PubMed ID: 9371228
[TBL] [Abstract][Full Text] [Related]
24. Cellular factors may enable squamous carcinoma cells to overcome TGF beta-mediated repression of CDK2 activity.
Lesaca EE; Ensley JF; Yeudall WA
Oral Oncol; 1998 Jan; 34(1):52-7. PubMed ID: 9659520
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma.
Nakamura R; Kayamori K; Oue E; Sakamoto K; Harada K; Yamaguchi A
Biochem Biophys Res Commun; 2015 Mar; 458(4):777-82. PubMed ID: 25681764
[TBL] [Abstract][Full Text] [Related]
26. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression.
Biasi F; Tessitore L; Zanetti D; Cutrin JC; Zingaro B; Chiarpotto E; Zarkovic N; Serviddio G; Poli G
Gut; 2002 Mar; 50(3):361-7. PubMed ID: 11839715
[TBL] [Abstract][Full Text] [Related]
27. Head and neck squamous cell carcinoma: prediction of cervical lymph node metastasis by dual-energy CT texture analysis with machine learning.
Forghani R; Chatterjee A; Reinhold C; Pérez-Lara A; Romero-Sanchez G; Ueno Y; Bayat M; Alexander JWM; Kadi L; Chankowsky J; Seuntjens J; Forghani B
Eur Radiol; 2019 Nov; 29(11):6172-6181. PubMed ID: 30980127
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling.
Dong H; Diao H; Zhao Y; Xu H; Pei S; Gao J; Wang J; Hussain T; Zhao D; Zhou X; Lin D
Cell Prolif; 2019 Sep; 52(5):e12633. PubMed ID: 31264317
[TBL] [Abstract][Full Text] [Related]
29. TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad pathway in squamous cell carcinoma of the head and neck.
Yu C; Liu Y; Huang D; Dai Y; Cai G; Sun J; Xu T; Tian Y; Zhang X
Oncol Rep; 2011 Jun; 25(6):1581-7. PubMed ID: 21479366
[TBL] [Abstract][Full Text] [Related]
30. Using probe electrospray ionization mass spectrometry and machine learning for detecting pancreatic cancer with high performance.
Chung WY; Correa E; Yoshimura K; Chang MC; Dennison A; Takeda S; Chang YT
Am J Transl Res; 2020; 12(1):171-179. PubMed ID: 32051746
[TBL] [Abstract][Full Text] [Related]
31. The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cells.
Moreno-Càceres J; Caballero-Díaz D; Nwosu ZC; Meyer C; López-Luque J; Malfettone A; Lastra R; Serrano T; Ramos E; Dooley S; Fabregat I
Cell Death Dis; 2017 Oct; 8(10):e3098. PubMed ID: 29022911
[TBL] [Abstract][Full Text] [Related]
32. Alterations of Smad expression and activation in defining 2 subtypes of human head and neck squamous cell carcinoma.
Xie W; Aisner S; Baredes S; Sreepada G; Shah R; Reiss M
Head Neck; 2013 Jan; 35(1):76-85. PubMed ID: 22275186
[TBL] [Abstract][Full Text] [Related]
33. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
Chen A
Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
[TBL] [Abstract][Full Text] [Related]
34. TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma.
Oshimori N; Oristian D; Fuchs E
Cell; 2015 Feb; 160(5):963-976. PubMed ID: 25723170
[TBL] [Abstract][Full Text] [Related]
35. [Cytokine expression of transforming growth factor-beta2 and interleukin-10 in squamous cell carcinomas of the head and neck. Comparison of tissue expression and serum levels].
Karcher J; Reisser C; Daniel V; Herold-Mende C
HNO; 1999 Oct; 47(10):879-84. PubMed ID: 10550371
[TBL] [Abstract][Full Text] [Related]
36. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
[TBL] [Abstract][Full Text] [Related]
37. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
38. Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma.
Gluck C; Glathar A; Tsompana M; Nowak N; Garrett-Sinha LA; Buck MJ; Sinha S
PLoS Genet; 2019 Jul; 15(7):e1008250. PubMed ID: 31306413
[TBL] [Abstract][Full Text] [Related]
39. Gramine inhibits angiogenesis and induces apoptosis via modulation of TGF-β signalling in 7,12 dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinoma.
Ramu A; Kathiresan S; Ali Ahmed B
Phytomedicine; 2017 Sep; 33():69-76. PubMed ID: 28887922
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of transforming growth factor beta receptors on head and neck squamous cell carcinoma tumor cells.
Eisma RJ; Spiro JD; von Biberstein SE; Lindquist R; Kreutzer DL
Am J Surg; 1996 Dec; 172(6):641-5. PubMed ID: 8988667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
